Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM)

Publié le 1 Janvier 2007
Mis à jour le 5 juillet 2019

We present the main results of the first population-based cancers survival study gathering all French registry data. Survival data on 205,562 cancer cases diagnosed between 01/01/1989 and 31/12/1997 were analysed. Relative survival was estimated using an excess rate model. The evolution of the excess mortality rate over the follow-up period was graphed. The analysis emphasised the effect of age at diagnosis and its variation with time after diagnosis. For breast and prostate cancers, the age-standardised five-year relative survivals were 84% and 77%, respectively. The corresponding results in men and women were 56% versus 58% for colorectal cancer and 12% versus 16% for lung cancer. For some cancer sites, the excess mortality rate decreased to low values by five years after diagnosis. For most cancer sites, age at diagnosis was a negative prognostic factor but this effect was often limited to the first year after diagnosis. (R.A.)

Auteur : Bossard N, Velten M, Remontet L, Belot A, Maarouf N, Bouvier AM, Guizard AV, Tretarre B, Launoy G, Colonna M, Danzon A, Molinie F, Troussard X, Bourdon Raverdy N, Carli PM, Jaffre A, Bessaguet C, Sauleau EA, Schvartz C, Arveux P, Maynadie M, Grosclaude P, Esteve J, Faivre J
European Journal of Cancer, 2007, vol. 43, n°. 1, p. 149-60